Document is current

Article History

Accepted: 6 July 2022

First Online: 29 July 2022

Declarations

:

: No funding was received. All authors are members of the North America Chapter of the International Society of Pharmacovigilance (NASoP), which is a non-profit scientific organization.

: Maribel Salas and Priyanka Yalamanchili are employees of Daiichi Sankyo, Inc. Jan Petracek is the founder and director of the Institute of Pharmacovigilance. Omar Aimer is an employee of Innovigilance. Dinesh Kasthuril is an employee of Labcorp Drug Development. Sameer Dhingra is Associate Professor and Head of Department of Pharmacy Practice at National Institute of Pharmaceutical Education and Research (NIPER), Hajipur. Toluwalope Junaid is an employee of Syneos Health. Tina Bostic is an employee of PPD, part of Thermo Fisher Scientific. The opinions and positions taken in this article are personal to the authors and not their employer/affiliated institutions.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: MS: study design, study implementation (title/abstract screening, quality control), preparation of draft manuscript, review of manuscript draft, and interpretation of results. JP: study design, study implementation (title/abstract screening), review of manuscript draft, and interpretation of results. PY: study design, study implementation (full article screening, quality control), preparation of draft manuscript, review of manuscript draft, and interpretation of results. OA: study design, study implementation (title/abstract screening, full article screening), review of manuscript draft, and interpretation of results. DK: study design, study implementation (full article screening), review of manuscript draft, and interpretation of results. SD: review of manuscript draft and interpretation of results. TJ: study implementation (quality control), review of manuscript draft, and interpretation of results. TB: study design, study implementation (title/abstract screening, quality control), review of manuscript draft, interpretation of results, quality control of summary table. All authors have read and approved the final version of the manuscript and agree to be accountable for the work presented.